Hsinchu, Taiwan

Hui-Ching Wang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: National Tsing Hua University. Active years: 2017-2021.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2017-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Hui-Ching Wang

Introduction

Hui-Ching Wang is a notable inventor based in Hsinchu, Taiwan. She has made significant contributions to the field of medical treatments, particularly in cancer and hepatitis therapies. With a total of 2 patents, her work reflects a commitment to advancing healthcare solutions.

Latest Patents

Hui-Ching Wang's latest patents include a method of treating cancer cells. This invention discloses a method that involves administering a composition comprising a rhodamine or rhodamine derivative conjugated to a peptide with an amino acid sequence of SEQ ID NO: 1 to a subject in need, followed by activating the composition with light. Another significant patent is directed towards using a heat shock protein inhibitor for treating hepatitis and hepatoma. This invention focuses on preparing a pharmaceutical composition that utilizes a heat shock protein inhibitor to scavenge hepatitis B virus-infected cells. The inhibitors mentioned include VER-155008, Pifithrin-α, and their pharmaceutical acceptable salts.

Career Highlights

Hui-Ching Wang is affiliated with Tsinghua University, where she continues her research and development in innovative medical treatments. Her work has garnered attention for its potential impact on treating serious health conditions.

Collaborations

Some of her notable coworkers include Dah-Tsyr Chang and Yu-Hsuen Tu, who contribute to her research endeavors.

Conclusion

Hui-Ching Wang's innovative approaches in treating cancer and hepatitis highlight her role as a leading inventor in the medical field. Her patents reflect a dedication to improving patient outcomes through advanced therapeutic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…